• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Incyte Corp

NASDAQ:INCY

$22.41 -$0.25 (-1.10%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

Incyte to Present at Upcoming Investor Conferences

5/23/2012 by Business Wire

Weekly CEO Sells Highlight: DIS, LMT, INCY, ADBE

5/14/2012 by Forbes

Incyte upgraded to Buy from Neutral at Goldman

5/11/2012 by Theflyonthewall.com

Incyte management to meet with Jefferies

5/4/2012 by Theflyonthewall.com

Incyte to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

5/1/2012 by Business Wire

Incyte Corp. (INCY) Broke Out To A New High On Q1 Earnings News

4/27/2012 by RTTNews

Incyte raises FY12 revenue view to $107M from $67M, consensus $203.04M

4/26/2012 by Theflyonthewall.com

Incyte reports Q1 EPS (36c), consensus (46c)

4/26/2012 by Theflyonthewall.com

Incyte Reports 2012 First-Quarter Financial Results; Updates Shareholders on Commercial Activity and Key Clinical Programs

4/26/2012 by Business Wire

Biotech names with the highest probability of M&A activity at Goldman

4/23/2012 by Theflyonthewall.com

Incyte announces EU regulatory milestone for ruxolitinib

4/20/2012 by Theflyonthewall.com

Incyte Announces EU Regulatory Milestone for Ruxolitinib

4/20/2012 by Business Wire

Cell Therapeutics Juggles Chainsaws To Distract Investors From Its Dead-End Course

4/19/2012 by TheStreet.com

Incyte to Report First Quarter 2012 Financial Results on April 26

4/10/2012 by Business Wire

Piper Jaffray's biotech and specialty pharma analysts hold a conference call

4/5/2012 by Theflyonthewall.com

Investing in Health Care Stocks

3/30/2012 by CNBC Video

Incyte initiated with a Buy at ThinkEquity

3/30/2012 by Theflyonthewall.com

Targacept and Incyte Corporation -- Strong Performers in Strengthening Biotechnology Industry

3/23/2012 by Marketwire

Phase III studies of Jakafi published in The New England Journal of Medicine

2/29/2012 by Theflyonthewall.com

Incyte to Present at Upcoming Investor Conferences

2/22/2012 by Business Wire

Top Analyst Upgrades & Downgrades (MO, AMZN, UHAL, AMLN, ACI, CAJ, CMCSA, DE, DLR, ENS, EQIX, INCY, LO, WFR, NWL, NVDA, PM, RENN)

2/16/2012 by 24/7 Wall Street

24/7 Wall St. Closing Bell (DELL, KMB, SWY, RAX, BAC, ANF, CMCSA, XEC, DE, DVN, INCY, NOR, TEVA, ZNGA, BPAX, CSKI, IPSU, ALNY, CYBI)

2/15/2012 by 24/7 Wall Street

Incyte sees FY12 revenues $67M from amortization of upfront payments received

2/15/2012 by Theflyonthewall.com

Incyte reports Q4 EPS (44c) vs. consensus (39c)

2/15/2012 by Theflyonthewall.com

Incyte to Present at the Leerink Swann 2012 Global Healthcare Conference

2/3/2012 by Business Wire

Incyte to Report Fourth Quarter/Year-End 2011 Financial Results on February 15

1/26/2012 by Business Wire

8 Stocks Rising on Monster Volume

1/23/2012 by TheStreet.com

Insiders Trading INCY, LOPE, STMP, HMA

1/23/2012 by TheStreet.com

Biotech Buyouts & Deal Flows

1/20/2012 by CNBC Video

5 Stocks Flashing 'Buy' Alerts

1/19/2012 by TheStreet.com

Insiders Trading INCY, APOL, GEOY, MSM

1/18/2012 by TheStreet.com

Incyte could become takeover target, MSN Money says

1/17/2012 by Theflyonthewall.com

Collins Stewart hosts events in conjunction with JP Morgan Healthcare Conference

1/9/2012 by Theflyonthewall.com

Incyte management to meet with Collins Stewart

1/3/2012 by Theflyonthewall.com

Top Biotech Stock Picks For 2012 (ARIA, DNDN, GILD, HGSI, ILMN, INCY, JAZZ, LIFE, THRX, IBB, XBI)

12/28/2011 by 24/7 Wall Street

Tomorrow's Monster Stock

12/23/2011 by The Motley Fool

Incyte to Present at the 30th Annual J. P. Morgan Healthcare Conference

12/20/2011 by Business Wire

Novartis says Phase III dats shows INC424 significantly reduced disease

12/13/2011 by Theflyonthewall.com

YM Bio's Myelofibrosis Drug Is For Real

12/12/2011 by TheStreet.com

7 Stocks Rising on Unusual Volume

12/12/2011 by TheStreet.com
See More Articles...